Michael O’Regan, Ph.D
Following completion of his PhD in Molecular Biology at the National University of Ireland, Michael entered industry and took up a position as a Research Scientist, and subsequently Project Leader, at French Biotechnology company, Transgene where he led applied research projects in biotechnology/molecular biology in the framework of contracts with multinational companies. He then joined Fidia Pharmaceuticals near Venice, Italy where he spent the following 15 years in various Management positions in R&D, Business Unit Management and Marketing. During this time he managed Fidia’s Osteoarticular portfolio and was instrumental in achieving first-in-class approval by US FDA for Fidia’s intra-articular hyaluronic acid, Hyalgan, and in establishing Fidia’s market leadership position in this segment.
Over the past 10 years, Michael has held Executive positions in various companies in the regenerative medicine field including: Wright Medical (European Marketing Director for OrthoBiologics), Anika Therapeutics (VP Marketing), Regen Lab (VP Business Development) and most recently, BONESUPPORT (Country Manager Italy, France, Spain).
In Regen Med, Michael will apply his strong scientific background and extensive international experience to the clinical translation of regenerative medicine therapies with a view to improving their impact on patients’ lives and on national health systems.